Zion Market Research Global Epigenetics Market, 2016–2024 | Page 4

Epigenetics Market
segment of the epigenetics market is sub-classified into methyltransferases, acetylases, and
other protein modifying enzymes.
Global Epigenetics Market: Regional Analysis
North America is assumed to dominate the global market for epigenetics in the near future
owing to the several factors, including the growing quantity of grant for R&D, rising cancer
incidence, elevated patient alertness levels, and the mounting associations between the large
pharmaceutical industries for manufacturing of enhanced therapeutics. The Asia Pacific is also
anticipated to grow in the market at a rapid pace in coming period. The growth of the market in
this region can be credited to factors such as the existence of huge occurrence of target
diseases and the huge unmet medical requirements.
Inquire more before buying this report @
https://www.zionmarketresearch.com/inquiry/epigenetics-market
Global Epigenetics Market: Competitive Players
The major players in the global epigenetics market are Sigma-Aldrich Corporation, Abcam,
Merck, Diagenode, and New England Biolabs. The other key players in the market include
Qiagen, Thermo Fisher Scientific, Illumina, Active Motif, and Zymo Research.